We found a similar behaviour in cholangiocarcinoma cells, wherein β-caryophyllene significantly increased the Tyr705 phosphorylation of STAT3, although the effect were at least 30-fold lower than that of doxorubicin: the STAT3 activation was also associated with enhanced ROS levels, without affecting DNA integrity [163]. Here, STAT3 is linked to cholangiocarcinoma.